About Sanara MedTech, Inc. 
Sanara MedTech, Inc.
Pharmaceuticals & Biotechnology
Sanara Medtech Inc., formerly Wound Management Technologies, Inc., formerly MB Software, Inc., distributes collagen-based wound care products to healthcare providers, such as physicians, clinics and hospitals. The Company's subsidiaries include Wound Care Innovations, LLC (WCI), Resorbable Orthopedic Products, LLC and Innovate OR, Inc. The Company's WCI provides CellerateRX product in the wound care market. CellerateRX is a medical device for use on all acute and chronic wounds, except third degree burns. CellerateRX is offered in both gel and powder form. WCI expanded its CellerateRX product line to include CellerateRX Surgical products.
Company Coordinates 
Company Details
1200 Summit Ave Ste 414 , FORT WORTH TX : 76102-4407
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 18 Schemes (5.22%)
Foreign Institutions
Held by 15 Foreign Institutions (1.38%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Ronald Nixon
Executive Chairman of the Board
Mr. J Carmena
Principal Executive Officer, Director
Mr. Robert DeSutter
Director
Ms. Sara Ortwein
Director
Ms. Ann Salamone
Director
Dr. Kenneth Thorpe
Director
Revenue and Profits:
Net Sales:
26 Million
(Quarterly Results - Jun 2025)
Net Profit:
-2 Million
Pharmaceuticals & Biotechnology
USD 318 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.78
-32.95%
8.99






